Laboratory Testing in Telogen Effluvium
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices.
INTRODUCTION
Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities … 
Chemical peels are the third most commonly performed noninvasive cosmetic procedure in the United States, with over 1 million peels performed annually.
Peels can treat a variety of skin conditions including acne, conditions of hyperpigmentation, and skin irregularities from chronic sun damage. Multiple peels on a repeated basis are usually necessary to obtain optimal results. The frequency of … 
INTRODUCTION
Common among adolescents and adults, acne vulgaris accounts for a significant portion of dermatology appointments.1 While there are a variety of safe, effective, and evidence-based treatments available, there are also numerous products for acne marketed on social media that are untested and/or show no benefit in treating acne vulgaris. Even for treatments with known efficacy, quality … 
Atopic Dermatitis Pathogenesis
Atopic dermatitis (AD) is a chronic inflammatory skin disease for which common symptoms are rash, itch, dryness, and redness. AD is a perfect example of what happens when skin barrier homeostasis is not maintained. In AD, the lipids that comprise the skin barrier are reduced in chain length compared with healthy skin, resulting in poor barrier function and increased … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu … 